Posts Tagged ‘osteoporosis’

52-Week High/Volume Surge: Amgen (AMGN)

The most active stock in pre-market trading is Amgen Inc. (NASDAQ: AMGN) after the company released its positive data on its osteoporosis treatment that Wall Street was awaiting.
This stock is surging to new 52-week highs and getting out from under a very large shadow since it has had almost nothing but problems since 2006.
Amgen has [...]